Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: A prospective randomised trial conducted in a clinical setting

Medical Journal of Australia

Volumn 192, Issue 12, 2010, Pages 686-689

  Hackman, Kathryn L ^a   Gagnon, Claudia ^a   Briscoe, Roisin K ^a   Lam, Simon ^b,c   Anpalahan, Mahesan ^a   Ebeling, Peter R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Austin Health   (United States)

^c Rheumatology Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CAL D FORTE; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; CREATININE; OSTEVIT D; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MALE; NEPHROLITHIASIS; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 77955651358     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03702.x     Document Type: Article

References (23)

1. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-285.
2. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomised controlled trial. J Bone Miner Res 2003; 18: 343-351.
3. Chatfield SM, Brand C, Ebeling PR, et al. Vitamin D deficiency in general medical inpatients in summer and winter. Inter Med J 2007; 37: 377-382.
4. Holick M. Vitamin D deficiency [review]. N Engl J Med 2007; 357: 266-281.
5. Flicker L, Mead K, MacInnis RJ, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003; 51: 1533-1538.
6. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays 2004; 26: 21-28.
7. Neale RE, Webb PM, van der Pols JC. Vitamin D for prevention of chronic disease: the need for continued research. Intern Med J 2008; 38: 813-815.
8. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85: 649-650.
9. Aloia JF, Patel M, Dimaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008; 87: 1952-1958.
10. Wu F, Staykova T, Horne A, et al. Efficacy of an oral, 10 day course of high dose cholecalciferol in correcting vitamin D deficiency. N Z Med J 2003; 116: U536.
11. 2 dose required to rapidly increase 25OHD in osteoporotic women. Eur J Clin Nutr 2006; 60: 681-687.
12. Khaw K-T, Scragg R, Murphy S. Single dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women: A randomized trial. Am J Clin Nutr 1994; 59: 1040-1044.
13. Weisman Y, Schen RJ, Eisenberg Z, et al. Single oral high dose Vitamin D3 prophylaxis in the elderly. J Am Geriatr Soc 1986; 34: 515-518.
14. Diamond TH, Ho KW, Rohi PG, Meerkin, M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005; 183: 10-12.
15. Veith R, Chan P-C R, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73: 288-294.
16. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res 2007; 22 Suppl 2: 64-68.
17. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856.
18. Bacon CJ, Gamble GD, Horne AM, et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009; 20: 1407-1415.
19. van der Mei IA, Ponsonby A-L, Engelsen O, et al. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007; 115: 1132-1139.
20. Cranney A, Horsley T, O'Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007; 158: 1-235.
21. Grant A, Avenell A, Campbell M, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomized Evaluation of Calcium Or vitamin D, RECORD): a randomized placebo-controlled trial. Lancet 2005; 365: 1621-1628.
22. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005; 330: 1003-1008.
23. Ebeling, PR. Mega therapy for vitamin D deficiency [editorial]. Med J Aust 2005; 183: 4-5.